MUMBAI: Fortis Healthcare (India) today
said its board will consider and approve the valuation for the proposed
acquisition of its Singapore-based arm, Fortis Healthcare International Pte
Ltd, tomorrow.
The valuation for the proposed acquisition
recommended by the independent committee of the board is pursuant to the
valuations carried out by independent valuer appointed for the purpose, Fortis
Healthcare (India) said in a filing to the BSE today.
The company had earlier announced that it will
acquire its Singapore-based arm Fortis Healthcare International Pte Ltd from a
firm owned by its promoters, the Singh brothers, as part of consolidation of
domestic and global operations.
"Our combined entity will leverage competitive
strengths and realise synergies to benefit all the operations, especially
leveraging the group's enormous talent in healthcare," company's Managing
Director Shivinder Mohan Singh had said earlier.
The consolidation of the two entities would create
a firm with consolidated revenues of $ 1 billion, with each entity contributing
$ 500 million each.
Fortis International, which was set up last
year to pursue overseas business, has made seven acquisitions in 10 markets,
including Hong Kong-based Quality HealthCare Asia.
It also bought Australia's Dental Corporation
Holdings, and Sri Lanka's Lanka Hospitals Corp Plc, among others.
Shares of Fortis Healtcare (India) today
closed at Rs 124.50 on BSE, down 0.24 per cent from its previous close.
The Economic Time
Business & Investment Opportunities
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Consulting, Investment and Management, focusing three main economic sectors: International PR; Healthcare & Wellness;and Tourism & Hospitality. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programs. Sign up with twitter to get news updates with @SaigonBusinessC. Thanks.

No comments:
Post a Comment